文献速递骨肌PETCT

F-18 FDG PET鉴别良性与恶性软骨性肿瘤:一项系统文献综述

F-18 FDG PET differentiation of benign from malignant chondroid neoplasms: a systematic review of the literature.
PubMed 文献 · Skeletal Radiol · 2017-06-12

该系统综述纳入8篇文献共166个病灶,评估PET-CT在鉴别良性软骨性肿瘤、低级别软骨肉瘤与2/3级软骨肉瘤中的效能。结果显示,良性肿瘤SUVmax为1.6±0.7,低于恶性肿瘤的4.4±2.5(p<0.0001);0/1级肿瘤SUVmax为2.0±0.7,低于2/3级的6.0±3.2(p<0.0001)。SUVmax随组织学分级升高而升高(Spearman ρ=0.78),SUVmax≥4.4对2/3级软骨肉瘤的特异度为99%。

要点

  • 良性软骨性肿瘤SUVmax为1.6±0.7,恶性为4.4±2.5,差异有统计学意义(p<0.0001)。
  • 0/1级软骨性肿瘤SUVmax为2.0±0.7,2/3级为6.0±3.2,差异有统计学意义(p<0.0001)。
  • SUVmax≥4.4对2/3级软骨肉瘤的特异度为99%。

核心结论

  • 在骨内软骨性肿瘤中,SUVmax与组织学分级相关;极低的SUVmax支持良性肿瘤诊断,而SUVmax升高提示更高级别软骨肉瘤。

研究设计与样本

  • 系统综述,检索PubMed和Embase共811篇文献,最终纳入8篇文献、166个病灶;提取年龄、性别、肿瘤大小、组织学分级和SUVmax,个体病灶数据可得时按个体提取,否则按汇总数据记录。

诊断标准与关键数值

  • 良性肿瘤SUVmax为1.6±0.7,恶性肿瘤为4.4±2.5(p<0.0001,t检验)。
  • 0/1级肿瘤SUVmax为2.0±0.7,2/3级肿瘤为6.0±3.2(p<0.0001,t检验)。
  • SUVmax随软骨性肿瘤分级升高而升高(Spearman秩相关,ρ=0.78)。
  • SUVmax≥4.4对2/3级软骨肉瘤的特异度为99%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: Discriminating among benign chondroid tumors, low-grade chondrosarcomas, and grade 2/3 chondrosarcomas is frequently difficult with standard imaging modalities. We systematically reviewed the literature to determine the performance of PET-CT in making this distinction.

METHODS: A systematic review was performed identifying 811 PubMed- and Embase-indexed articles containing combinations of "chondrosarcoma," "enchondroma," "chondroid," "cartilage" and "PET/CT," "PET," "positron." Eight articles including 166 lesions were included. Age, gender, tumor size, histologic grade, and SUVmax values were extracted for individual lesions when possible and otherwise recorded as aggregated data. Comparisons in SUVmax among benign, low-grade, and intermediate-/high-grade chondroid neoplasms were made.

RESULTS: Individual SUVs were available for 101 lesions; 65 additional lesions were reported as aggregated data. There were 101 malignant and 65 benign tumors. Benign tumors were seen more frequently in females (p = 0.04, Fischer's exact test), but malignancy was not associated with age or lesion size. SUVmax was lower for benign (1.6 ± 0.7) than malignant tumors (4.4 ± 2.5) (p < 0.0001, t-test). SUVmax was lower for grade 0/1 (2.0 ± 0.7) than grade 2/3 (6.0 ± 3.2) (p < 0.0001, t-test). Increasing SUVmax correlated with higher grade chondroid tumors (Spearman's rank, ρ = 0.78). SUVmax ≥4.4 was 99% specific for grade 2/3 chondrosarcoma.

CONCLUSIONS: SUVmax correlates with histologic grade in intraosseous chondroid neoplasms; very low SUVmax supports a diagnosis of benign tumor, while elevated SUVmax is suggestive of higher grade chondrosarcoma.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Subhawong TK, Winn A, Shemesh SS, et al. F-18 FDG PET differentiation of benign from malignant chondroid neoplasms: a systematic review of the literature. Skeletal Radiol. 2017. PMID: 28608242. doi:10.1007/s00256-017-2685-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。